[Blood purification and endotoxin].
Suzue
Nobuyuki
N
Kawashima Hospital.
Minakuti
Jyun
J
D000686:Amyloidosis / Q000209:etiology / Q000517:prevention & control; D016207:Cytokines / Q000378:metabolism; D015314:Dialysis Solutions / Q000009:adverse effects / Q000737:chemistry* / Q000592:standards; D004340:Drug Contamination; D004731:Endotoxins / Q000009:adverse effects* / Q000302:isolation & purification; D007249:Inflammation / Q000209:etiology / Q000517:prevention & control; D018836:Inflammation Mediators / Q000378:metabolism; D008070:Lipopolysaccharides / Q000009:adverse effects* / Q000302:isolation & purification; D009995:Osmosis; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation; D014871:Water Microbiology; D018508:Water Purification / Q000379:methods; D001613:beta 2-Microglobulin / Q000009:adverse effects / Q000302:isolation & purification
D016207:Cytokines; D015314:Dialysis Solutions; D004731:Endotoxins; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D001613:beta 2-Microglobulin